Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2020-09-18 Major Shareholding Noti…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding where Avanza Bank Holding AB, acting for a pension insurance subsidiary, acquired shares in Episurf Medical AB, resulting in their total holding crossing a threshold (5.07% shares, 5.02% voting rights). The structure, including 'Before the transaction', 'After the transaction', and 'Resulting distribution of total holdings', is characteristic of a major shareholding notification. The document explicitly mentions 'Reason for major shareholding notification Buy'. This directly corresponds to the Major Shareholding Notification category (MRQ). The document length is short (3490 chars), but it is the primary filing itself, not an announcement of a report.
2020-09-18 English
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding percentage ('4.92 %' changing to '4.87 %') and the corresponding number of underlying shares (9,104,586). The section header 'Reason for major shareholding notification Sell' confirms this is a notification regarding a significant change in ownership. This directly corresponds to the definition of Major Shareholding Notification (MRQ). The document is short and contains the necessary disclosure details, not an announcement of a larger report.
2020-09-16 English
Episurf Medical ger mål för marknadsandel vid dagens kapitalmarknadsdag
Investor Presentation Classification · 1% confidence The document is titled 'Episurf Medical ger mål för marknadsandel vid dagens kapitalmarknadsdag' (Episurf Medical sets market share targets at today's Capital Markets Day). It explicitly discusses an event called the 'Digitala Kapitalmarknadsdag' (Digital Capital Markets Day) where the company presents its operations, technology, clinical results, and future opportunities, including setting market share goals and commenting on Q3 commercial activity. This content strongly aligns with an Investor Presentation (IP) or a presentation associated with a specific investor event. Since the document is announcing and summarizing the content of a dedicated investor event (Capital Markets Day), 'Investor Presentation' (IP) is the most appropriate classification, as it details strategy, financials, and market position for investors. It is not a general earnings release (ER) or a comprehensive quarterly report (IR).
2020-09-15 Swedish
Episurf Medical provides market share target at today's Capital Markets Day
Investor Presentation Classification · 1% confidence The document explicitly announces that the company, Episurf Medical, is hosting a 'Digital Capital Markets Day' today. It details the purpose of this event, which includes presenting business strategy, technology, clinical results, and providing market share targets. A Capital Markets Day presentation is a specific type of investor event focused on long-term strategy and financial outlook, which aligns best with the Investor Presentation (IP) category, as it is a detailed presentation for investors. Although it mentions commenting on Q3 commercial activity, the primary focus is the forward-looking presentation event itself, not a formal Earnings Release (ER) or Interim Report (IR). Since it is a presentation being delivered, IP is the most appropriate classification.
2020-09-15 English
Results from European multicentre study with follow-up of 80 Episealer® patients accepted for publication in Knee Surgery, Sports Traumatology, Arthroscopy (KSSTA)
Regulatory Filings Classification · 1% confidence The document is a press release announcing that a clinical study regarding the company's Episealer product has been accepted for publication in a medical journal. It does not contain financial statements, board changes, or regulatory filings, but rather serves as a general corporate announcement regarding company research and development progress. As it does not fit into specific categories like 10-K, ER, or M&A, it falls under the general regulatory announcement category.
2020-09-15 English
Resultat från europeisk multicenterstudie med uppföljning av 80 Episealer®-patienter godkända för publicering i Knee Surgery, Sports Traumatology, Arthroscopy (KSSTA)
Regulatory Filings Classification · 1% confidence The document is a press release from Episurf Medical announcing that a clinical study regarding their Episealer product has been accepted for publication in a medical journal. It does not fit into financial reporting categories like 10-K, IR, or ER, nor is it a regulatory filing for a specific corporate event like a dividend or board change. As it is a general corporate announcement regarding company activities (clinical research progress) that does not fall into the other specific categories, it is classified as a Regulatory Filing (RNS).
2020-09-15 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.